1. Thailand Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Bangkok Chain Hospital Public Company Limited

Bangkok Chain Hospital Public Company Limited

BCH-R.BK
Bangkok Chain Hospital Public Company LimitedTH flagStock Exchange of Thailand
9.95
THB
-0.25
- -
24.81BMarket Cap
Bangkok Chain Hospital Public Company Limited
BCH-R.BK
(Stock Exchange of Thailand)

Recent

price

9.95

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
1.75
1.56
1.79
1.89
2.14
2.33
2.63
2.93
3.26
3.59
3.6
8.6
7.58
4.73
4.73
4.81
4.9
Revenue per Share
0.26
0.27
0.36
0.23
0.21
0.21
0.3
0.37
0.44
0.46
0.49
2.75
1.22
0.56
0.51
0.53
0.52
Basic EPS, GAAP
0.22
0.18
-0.04
-0.29
0.04
0.3
0.39
0.28
0.14
0.06
-0.34
2.2
1.71
1.27
0.42
0.62
0.43
Free Cash Flow per Basic Share
0.21
0.1
0.2
0.1
0.13
0.12
0.14
0.18
0.23
0.22
0.23
0.33
1.4
0.5
0.37
0.43
0.44
Dividend per Share
1
0.96
1.12
1.24
1.3
1.4
1.56
1.74
1.94
2.18
2.44
4.89
4.71
4.77
4.91
5.01
5.22
Book Value per Share
1.4
1.36
1.54
1.72
1.76
1.79
1.95
2.18
2.38
2.62
2.88
5.56
5.19
5.27
5.4
5.48
5.76
Tangible Book Value per Share
2,494
2,494
2,494
2,494
2,494
2,494
2,494
2,494
2,494
2,494
2,494
2,494
2,494
2,494
2,494
2,494
2,447
Basic Weighted Avg Shares
4,370
3,903
4,466
4,702
5,336
5,810
6,562
7,303
8,131
8,953
8,980
21,454
18,895
11,804
11,794
11,984
11,985
Sales/Revenue/Turnover
24.93
28.82
30.28
21.38
18.93
18.55
19.35
20.77
20.3
19.07
20.34
44.28
22.19
16.6
14.51
15.12
14.38
Operating Margin (%)
221
223
238
345
433
461
514
538
576
665
782
874
950
944
998
1,067
1,078
Depreciation Expense
639
673
908
585
522
527
753
917
1,089
1,135
1,229
6,846
3,039
1,406
1,282
1,316
1,263
Net Income, GAAP
28.53
29.65
23
19.76
19.2
20.57
18.27
19.5
18.59
18.05
18.35
19.74
21.96
21.48
19.77
22.03
22.12
Effective Tax Rate (%)
14.62
17.24
20.34
12.44
9.78
9.08
11.48
12.56
13.4
12.68
13.69
31.91
16.08
11.91
10.87
10.98
10.53
Profit Margin (%)
680
-554
321
457
130
-905
-685
1,088
808
781
-2,129
5,694
3,325
1,338
895
958
1,087
Working Capital
717
19
1,393
3,517
3,418
2,526
2,498
4,344
4,354
4,759
3,027
4,060
2,613
334
266
238
234
LT Debt
3,684
3,601
4,064
4,546
4,667
4,922
5,337
5,912
6,398
6,978
7,626
14,306
13,510
13,704
14,027
14,207
14,502
Total Equity
17.36
16.15
18.68
10.68
9.2
9.31
10.96
11.65
11.85
11.8
10.84
40.58
16.42
9.44
9.08
9.42
8.82
Return on Invested Capital (%)
13.13
14.29
17.06
8.08
6.32
6.17
8.23
8.64
9.94
9.86
9.11
36.35
16.33
9.01
8.36
8.71
8.28
Return on Capital (%)
26.92
27.57
34.98
19.86
16.45
15.67
20.47
22.33
23.74
22.09
21.36
74.93
25.4
11.9
10.62
10.64
9.97
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
901
633
457
LT Borrowings
232
223
222
LT Finance Leases
18
15
12
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2,494
2,494
2,494
Market Capitalization
31,975
25,580
23,731

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
3,668
3,798
3,713
Cash, Cash Equivalents & STI
1,484
1,694
1,402
Accounts Receivable, Net
820
633
619
Inventories
304
322
362
Total Current Liabilities
2,935
2,840
2,626
Payables & Accruals
1,841
2,028
1,990
ST Debt
901
633
457
Deferred Revenue
80
81
78

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.29%
17.42%
1.28%
Free Cash Flow
-157.59%
-164.74%
47.2%
Net Income, GAAP
43.72%
68.27%
2.65%
Sales/Revenue/Turnover
13.7%
18.19%
1.62%
Total Cash Common Dividend
36.73%
58.83%
16.22%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,862
2,875
3,278
2,780
11,794
2025
2,922
3,039
3,051
2,972
11,984
2026
2,923
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.13
0.11
0.18
- -
0.51
2025
0.13
0.16
0.14
- -
0.53
2026
0.11
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.25
0.12
- -
0.37
2025
- -
0.29
0.15
- -
0.43
2026
- -
- -
- -
- -
- -
Similar Companies
Clarity Medical Group Holding Limited (1406.HK)
Orpea S.A. (0NEX.L)
Principal Capital Public Company Limited (PRINC.BK)
Wellbeing Digital Sciences Inc. (KONEF)
Stem Cell Authority, Ltd. (SCAL)
BenQ BM Holding Cayman Corp. (2581.HK)
Business
Bangkok Chain Hospital Public Company Limited (BCH) operates a network of private hospitals and clinics in Thailand and Laos, providing comprehensive primary to tertiary healthcare services to Thai, international, and Social Security patients. Founded in 1984 and headquartered at 44 Moo 4, Chaengwattana Road, Pakkred, Nonthaburi, Thailand, the company manages four hospital groups—World Medical Hospital Group, Kasemrad International Hospital Group, Kasemrad Hospital Group, and Karunvej Hospital Group—comprising 16 hospitals, two polyclinics, one radiation oncology clinic, and five mobile dental buses with 2,323 licensed beds and 684 exam rooms across locations in Bangkok vicinity, Chiang Rai, Saraburi, Nonthaburi, Pathumthani, Ayutthaya, Chachoengsao, Prachinburi, Sa Kaeo, and Vientiane, Laos. Core services include heart centers offering early diagnosis, treatment, prevention, rehabilitation, and open-heart surgery; diagnostic imaging and radiation centers; eye centers for examinations, treatments, and surgeries; cancer centers providing screening, diagnosis, and chemotherapy; fertility centers utilizing blastocyst culture technology; diabetic wound care; comprehensive dental services; and dialysis treatment with advanced hemodialysis machines; additional businesses encompass health drink sales, medical analysis and research, and computer program development for healthcare. Recent developments feature the grand opening of Kasemrad Hospital Pathumthani in August 2025 following its rebranding from Karunvej Pathum Thani Hospital on January 1, 2025, alongside the opening of a heart center at Kasemrad Hospital Chachoengsao in January 2024 and the Kasemrad Ari Radiation Oncology Clinic; Kasemrad International Hospital Vientiane achieved JCI accreditation in September 2025 as the first in Laos, building on its 2021 launch via a partnership with RATCH Group acquiring a 9.91% stake in Bangkok Chain International (Lao) Co., Ltd. BCH targets double-digit revenue growth in 2025 driven by rebounding Social Security patient volumes at rebranded facilities and improved performance at three new hospitals, while evaluating potential acquisitions from financially troubled groups and pursuing expansion to 20 hospitals by 2028 focused on eastern Thailand and the Eastern Economic Corridor. The company earned SET ESG Ratings "AA" in December 2024, Outstanding Investor Relations Award at SET Awards 2025 for the second year, and eighth consecutive year on the ESG100 list in July 2025, reflecting sustained commitment to governance and sustainability.